KPTI
Karyopharm Therapeutics Inc
Price:  
0.98 
USD
Volume:  
1,123,501.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI Fair Value

-737.05 %
Upside

As of 2024-06-22, the Fair Value of Karyopharm Therapeutics Inc (KPTI) is -6.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.98 USD, the upside of Karyopharm Therapeutics Inc is -737.05%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.98 USD
Stock Price
-6.21 USD
Fair Price
FAIR VALUE CALCULATION

KPTI Fair Value

Peter Lynch's formula is:

KPTI Fair Value
= Earnings Growth Rate x TTM EPS
KPTI Fair Value
= 5.00 x -1.24
KPTI Fair Value
= -6.21

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -199.60 -196.30 -124.10 -165.30 -143.10 -165.68
YoY growth -11.88% 1.65% 36.78% -33.20% 13.43% 1.36%

KPTI Fair Value - Key Data

Market Cap (mil) 114.83
P/E
Forward P/E
EPS -1.24
Avg earnings growth rate 1.36%
TTM earnings -146.30